Community oncology faces significant challenges from the Inflation Reduction Act's (IRA) drug pricing changes, risking financial stability and patient access to care.

Prescription drugs | Image credit: Eric Hood - stock.adobe.com

5 Major Issues Keeping Patients From Life-Saving Medication

By Julia Bonavitacola

May 30th 2025

A new State of Drug Access report shows that more than 40% of people living in the US could not afford their prescribed drugs.

Contributor: Yearly Trends in Coverage Rates for GLP-1 RAs in Weight Loss

By Max Son, PharmD, MBA
Alison M. Edwards

Brianne Burns

May 29th 2025

Explore the evolving landscape of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for obesity, highlighting access challenges and payer coverage trends affecting treatment options.

Health Equity & Access Weekly Roundup: May 26, 2025

By Giuliana Grossi

May 26th 2025

This week, the Center on Health Equity & Access covered news from the Trump administration and CMS, Cigna's co-pay cap on weight loss drugs, and perspectives on living with HIV.

Weight loss medication | Image Credit: alones - stock.adobe.com

Evernorth Launches Co-Pay Cap for Weight Loss Drugs Amid New Federal Drug Pricing Effort

By Brooke McCormick

May 22nd 2025

Evernorth has capped antiobesity drug monthly co-pays at $200 in a move to improve access and affordability amid new drug pricing initiatives.

...

64 65 66 67 68

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions